Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide association study of loss of heterozygosity and metastasis-free survival in breast cancer patients.

Experimental oncology - 1 Jul 2017

Deryusheva I V, Tsyganov M, Garbukov E Y, Ibragimova M K, Kzhyshkovska Ju G, Slonimskaya E, Cherdyntseva N V, Litviakov N V

Abstract excerpt

One of the factors providing the diversity and heterogeneity of malignant tumors, particularly breast cancer, are genetic variations, due to gene polymorphism, and, especially, the phenomenon of loss of heterozygosity (LOH). It has been shown that LOH in some genes could be a good prognostic marker. AIM: To perform genome-wide study on LOH in association with metastasis-free survival in breast cancer. MATERIALS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Loss of Heterozygosity

Share to Neoplasm Grading

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Oligonucleotide Array Sequence Analysis

Share to Survival Analysis

Source

Identifiers

PMID: 29483489

Genes

CYSLTR1
PGK1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide association study of loss of heterozygosity and metastasis-free survival in breast cancer patients.PMID 29483489Read ↗

A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer.Semantic proximity Read ↗

Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer ProgressionSemantic proximity Read ↗

Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing.Semantic proximity Read ↗

Genetic losses in breast cancer: toward an integrated molecular cytogenetic map.Semantic proximity Read ↗

Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.Semantic proximity Read ↗

Clinical significance of genome-wide minimally deleted regions in oral squamous cell carcinomas.Semantic proximity Read ↗

Loss of heterozygosity analyzed by single nucleotide polymorphism array in cancer.Semantic proximity Read ↗

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.Semantic proximity Read ↗

Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer.Semantic proximity Read ↗

Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas.Semantic proximity Read ↗

Cancer classification using loss of heterozygosity data derived from single-nucleotide polymorphism genotyping arrays.Semantic proximity Read ↗

Conditional random pattern algorithm for LOH inference and segmentation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.